Page results
-
This information will help you understand your forthcoming treatment and contains answers to many frequently asked questions.
-
Between April 2021 and March 2022, 40% of UCLH outpatient appointments took place virtually - a total of 484,872 appointments – the highest in England.
-
UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and Neuro-oncology service to patients.
-
Brooke Robinson tells us what it is like to work to in neuroradiography at the National Hospital for Neurology and Neurosurgery.
-
This information has been written for patients who are having internal vaginal radiotherapy treatment (brachytherapy) for a gynaecological cancer.
-
Many of our consultants in infectious and tropical diseases hold the only dedicated NHS positions in their respective fields, including parasitology, leprosy, leishmaniasis, and tropical dermatology.
-
This page provides information about the support you can have with some of your concerns while living with myeloma.
-
The Royal National Ear Nose and Throat Hospital is a national and international centre for voice disorders. The voice service includes four consultant laryngologists, eight speech and language therapists and specialist nurses.
-
This information has been written for patients who have been referred for pelvic radiotherapy for a gynaecological cancer.
-
School training dates for September 2020 including an Eventbrite link
File results
-
FOI/2022/0611 - FTE staff, student staff, patients and attendances, bed numbers and occupancy
-
FOI2017190 Consultants undertaking private work
-
FOI2017189 Cost and number of tattoos removed
-
FOI2017188 Thefts from patients
-
FOI/2022/0623 - Integration/ workflow solutions across multiple technology systems
-
FOI/2022/0625 - Lung cancer treatment
-
FOI/2022/0630 - Patients exclusion at Trust hospitals
-
FOI2017186 Cyber security and cyber attacks
-
FOI/2022/0637 - Breast cancer treatment
-
FOI/2022/0660 - Prostate cancer